Does LOPINAVIR Cause Intentional product use issue? 47 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Intentional product use issue have been filed in association with LOPINAVIR (Kaletra). This represents 3.8% of all adverse event reports for LOPINAVIR.
47
Reports of Intentional product use issue with LOPINAVIR
3.8%
of all LOPINAVIR reports
37
Deaths
41
Hospitalizations
How Dangerous Is Intentional product use issue From LOPINAVIR?
Of the 47 reports, 37 (78.7%) resulted in death, 41 (87.2%) required hospitalization, and 3 (6.4%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOPINAVIR. However, 47 reports have been filed with the FAERS database.
What Other Side Effects Does LOPINAVIR Cause?
Foetal exposure during pregnancy (244)
Exposure during pregnancy (184)
Virologic failure (170)
Drug resistance (134)
Off label use (133)
Lipodystrophy acquired (126)
Premature baby (107)
Diplopia (89)
Treatment failure (89)
Premature delivery (88)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which LOPINAVIR Alternatives Have Lower Intentional product use issue Risk?
LOPINAVIR vs LOPINAVIR\RITONAVIR
LOPINAVIR vs LOPRAZOLAM
LOPINAVIR vs LORATADINE
LOPINAVIR vs LORATADINE\PSEUDOEPHEDRINE
LOPINAVIR vs LORAZEPAM